Products

WellDoc BlueStar
WellDoc
Cardiology AI
WellDoc BlueStar is an FDA-cleared, AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure.

See all 1 product →

About WellDoc

WellDoc is an AI-powered health technology company that specializes in transforming chronic disease management. Their comprehensive digital health platform offers multi-condition support for prediabetes, diabetes, hypertension, heart failure, weight and obesity management (including GLP-1 support), and integrated mental well-being and sleep support.

The company’s flagship product, BlueStar®, is an FDA-cleared digital therapeutic that provides personalized, real-time feedback, coaching, and educational content to improve patient outcomes and reduce healthcare costs. WellDoc’s platform leverages healthcare-ready AI, combining rules-based, machine learning, and generative AI to deliver personalized digital coaching and actionable insights. This approach is built on extensive clinical rigor, boasting 11 FDA clearances, 69 patents, and over 100 peer-reviewed publications. WellDoc partners with various healthcare sectors, including life sciences and medical devices, health plans, health systems, and employers, to extend care beyond traditional models.

Focus Areas

Type 1 Diabetes Type 2 Diabetes Pre-diabetes Gestational Diabetes Hypertension Heart Failure Weight Management Obesity Management GLP-1 Support Mental Well-being Sleep Apnea Chronic Kidney Disease (CKD) Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Business Intelligence

TechnologyAI-powered, healthcare-ready AI, proprietary algorithms, clinical-first training, device-agnostic, integrates with 400+ devices and data sources (CGMs, blood glucose monitors, blood pressure cuffs, weight scales, fitness trackers, labs, pharmacies), EHR integration, cloud-native (Databricks Data Intelligence Platform), specialized Large Sensor Models (LSMs), novel hybrid machine learning, transformer-based approaches, API/SDK integration

What Physicians Need to Know

Type 1 & Type 2 Diabetes
Welldoc offers FDA-cleared solutions for Type 1 and Type 2 Diabetes, providing secure capture, storage, and transmission of glucose data, information to aid in self-management, analysis and reporting of glucose test results, and medication adherence support. The platform also delivers personalized coaching messages (motivational, behavioral, and educational) based on real-time glucose values and trends.
Pre-diabetes
The Welldoc App is a Software as a Medical Device (SaMD) intended for use by healthcare providers and patients aged 18 and older with prediabetes.
Gestational Diabetes
Welldoc's platform supports diabetes in pregnancy, including gestational diabetes.
Hypertension
Welldoc provides an FDA-cleared AI solution for individuals to manage hypertension, often alongside diabetes.
Heart Failure
The Welldoc App is intended for use by healthcare providers and patients aged 18 and older who have heart failure.
Weight Management & Obesity Management
Welldoc offers a comprehensive solution for weight management and obesity, with or without GLP-1 medication support. This includes AI-driven digital coaching, lifestyle support, medication management, and integration with GLP-1 prior authorization.
GLP-1 Support
The platform provides specific support for individuals using GLP-1 medications for weight management, including medication management and integration with GLP-1 prior authorization.
Mental Well-being
The Welldoc App supports mental well-being as part of its multi-condition platform.
Sleep Apnea
The Welldoc App is intended for use by healthcare providers and patients aged 18 and older who have sleep apnea.
Chronic Kidney Disease (CKD)
Welldoc addresses chronic kidney disease as a specialty condition.
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Welldoc addresses MASH (formerly NASH) as a specialty condition.
Physician Tip

Welldoc's platform is designed to empower physicians with actionable insights and streamline care. The AI-powered platform provides continuous data analysis and feedback, enabling care teams to identify risks earlier and intervene proactively. It offers a provider and care team dashboard that can integrate into existing EMRs (like Epic) and care management platforms, allowing clinicians to view patient health data and communicate directly with patients within their existing workflows. The clinically validated and rigorously vetted AI, backed by 11 FDA clearances and over 100 peer-reviewed publications, offers personalized digital coaching and predictive intelligence to support improved cardiometabolic outcomes. This shifts care from reactive, episodic visits to continuous, proactive health management, providing a 360-degree view of patients by translating connected data from multiple sources.

Welldoc's platform is built for seamless integration into various healthcare ecosystems. It is device-agnostic, connecting with CGMs, blood glucose meters, blood pressure monitors, activity trackers, weight scales, and over 400 other devices and data sources. The platform integrates directly into EMR and care management platforms, allowing care teams to work within their existing systems. Welldoc also offers flexible integration options via SDK or API and provides white-label solutions, allowing partners to extend their brand. They partner with life sciences, medtech, health plans, health systems, and employers to integrate their technology into novel cardiometabolic health programs at scale.

Products by WellDoc

1 product in the directory

WellDoc BlueStar
WellDoc
Cardiology AI
WellDoc BlueStar is an FDA-cleared, AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure.

What the Web Says

WellDoc is an AI-powered health technology company focused on cardiometabolic care, including diabetes, obesity, hypertension, and heart failure. The company and its products generally receive positive reviews, particularly regarding its workplace culture and the clinical rigor of its AI-driven platform. However, some users have reported issues with the mobile application's functionality.

Overall: Positive

Strengths

  • Strong, collaborative, and welcoming company culture.
  • High employee satisfaction, with 95% of employees calling it a great place to work.
  • AI-powered platform provides personalized digital coaching and insights.
  • Clinically validated with 11 FDA clearances and over 100 peer-reviewed publications.
  • Offers flexible schedules and interesting technology for employees.
  • Recognized as a 'Best Overall Digital Health Company' for four consecutive years.

Limitations

  • Mobile application can be buggy, with issues like purged data and connectivity problems.
  • Some users reported the app recording medication intake on its own.
  • Limited number of recent product reviews available on major platforms like G2 and Capterra.
  • The app is only available through health plans, health systems, or employers, limiting direct access for individuals.

Based on reviews from: Indeed.com, Great Place To Work®, Business Wire, G2, Apple App Store, The Healthcare Technology Report, Digital Therapeutics Alliance

Last updated: 2026-10-18

Videos

News, demos, and interviews about WellDoc.

Loading videos...

Videos load interactively. If none appear, search YouTube for WellDoc →

View all on YouTube

Press & Coverage

Welldoc
Welldoc Launches AI-Powered Care Loop Connecting Daily Health to Care Teams, Keeping Patients and Clinicians in Control
Welldoc launched its next-generation AI-powered care loop platform, designed to connect an individual's daily health experience directly to their care team through clinically validated Small Language Models (SLMs) and an AI care agent named Simon. The platform is backed by 11 FDA clearances, 69 patents, and over 100 peer-reviewed clinical publications.
2026-09
The Healthcare Technology Report
Welldoc Taps Michael Acker to Expand Health Plan and Life Sciences Partnerships
Welldoc appointed Michael Acker as Chief Growth Officer to expand partnerships with health plans, health systems, and life sciences companies, aiming to scale its digital coaching business beyond cardiometabolic conditions into areas like brain health, oncology, and immunology. Acker will lead commercial strategy and partnerships for programs serving people with complex health needs.
2026-10
Business Wire
Welldoc Goes Live on CMS ACCESS Model as Credentialed Medicare Part B Supplier to Deliver Scalable Digital-First Chronic Care
Welldoc is now an approved participant in the Centers for Medicare & Medicaid Services (CMS) Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model, allowing eligible Medicare beneficiaries to access the Welldoc App through the Medicare App Library at no out-of-pocket cost. This initiative aims to scale outcome-based cardiometabolic care.
2026-07
Welldoc
Welldoc Submits 510(k) to FDA for CGM-Informed Glucose Prediction Feature
Welldoc submitted a 510(k) premarket notification to the FDA for its Continuous Glucose Monitor (CGM)-Informed Glucose Prediction Feature, which predicts glucose values up to 2 hours for individuals with type 2 diabetes not using insulin. This builds on their 11 prior FDA 510(k) clearances.
2026-01
Welldoc
Welldoc Bridges the Insulin Dosing Gap with New Real-World Evidence
Welldoc announced new real-world evidence demonstrating improved time in range (TIR) through the use of its Continuous Glucose Monitor (CGM)-informed insulin bolus calculator. This tool helps people with insulin-dependent diabetes better manage their glucose levels, with studies showing significant improvements in TIR.
2026-03
Welldoc
Welldoc Brings AI-Powered Cardiometabolic Care to 68 Million Medicare Beneficiaries Through the ACCESS Model and Medicare App Library
Welldoc was selected by CMS to participate in the ACCESS Model, bringing its AI-driven clinical platform to Medicare beneficiaries with diabetes, obesity, hypertension, and prediabetes. The company will participate in both the Cardio-Kidney-Metabolic (CKM) and Early CKM (eCKM) tracks.
2026-04
Welldoc
Welldoc Cements AI Leadership with Dedicated AI Lab and 100+ Clinical Publications
Welldoc launched its AI Lab and announced over 100 peer-reviewed clinical publications, including 43 focused on advanced AI, alongside 11 FDA clearances and 60 patents. These achievements highlight Welldoc's commitment to clinical rigor and evidence-based AI innovation in cardiometabolic health solutions.
2025-11
diaTribe.org
Welldoc Receives $20 Million to Support BlueStar, an FDA-Approved Mobile Prescription Therapy
WellDoc received $20 million in funding, including support from Merck's Global Health Innovation Fund, to support the rollout of BlueStar, an FDA-approved mobile prescription therapy for type 2 diabetes self-management. The financing will fund a sales force to expand BlueStar's reach across the country.
2021-08

Frequently Asked Questions

WellDoc's platform primarily focuses on chronic condition management, with a strong emphasis on Type 1 Diabetes, Type 2 Diabetes, and Pre-diabetes. Additionally, it extends its support to areas such as Hypertension, Heart Failure, Weight Management, Obesity Management, GLP-1 Support, Mental Well-being, Sleep Apnea, Chronic Kidney Disease (CKD), and Metabolic Dysfunction-Associated Steatohepatitis (MASH).
WellDoc employs a multi-faceted approach to drive patient compliance and engagement, leveraging personalized coaching, educational content, and behavioral science principles embedded within its platform. The goal is to empower patients with tools and insights to actively manage their conditions and improve health outcomes.
WellDoc offers a suite of digital health solutions, including its flagship BlueStar® platform, which provides real-time feedback, education, and coaching to patients. These solutions are designed to integrate seamlessly with existing electronic health records (EHRs) and clinical workflows, enabling healthcare providers to remotely monitor patient data and make informed decisions.
WellDoc's pricing model is typically structured to accommodate various healthcare settings and patient populations. While specific details may vary, it generally involves a subscription-based approach, offering a cost-effective solution for chronic disease management compared to traditional care models.
WellDoc provides comprehensive support to both healthcare providers and patients. This includes dedicated account management, technical support, and clinical training for providers, as well as patient onboarding, ongoing technical assistance, and access to educational resources for users of the platform.
WellDoc actively collaborates with a range of partners, including pharmaceutical companies, health plans, and other healthcare organizations, to expand its reach and enhance its offerings. These partnerships often focus on integrating WellDoc's solutions into broader care pathways and improving access for eligible patients.
WellDoc has a strong track record as a pioneer in the digital health space, with a commitment to continuous innovation and evidence-based solutions. The company's long-term vision is to remain at the forefront of chronic condition management, expanding its platform to address a wider range of conditions and improve health outcomes globally.

Investors

Who's funded WellDoc.

Related Companies

Steer Health is an AI-powered growth and automation platform designed to optimize patient experiences and enhance revenue for healthcare organizations. The company’s platform utilizes artificial intelligence to automate various administrative tasks, including eligibility checks, referrals, payments, and patient intake. This automation facilitates personalized online scheduling, appointment reminders, and patient communication services, ultimately aiming to improve […]

Xealth is a healthcare AI company that provides a care orchestration platform designed to seamlessly integrate digital health tools and programs into existing clinical workflows. For physicians, this means the ability to prescribe and monitor digital health content, applications, and services directly from within their Electronic Health Record (EHR) system, much like ordering traditional medications. […]

EXF Health, a vertical of Exafluence, focuses on enhancing healthcare organizations by strengthening their health IT infrastructure and improving their analytics and data maturity. The company leverages best-in-class AI/ML tools and techniques to add continuous value to all healthcare participants. For healthcare payers, EXF Health offers executive decision boards that provide actionable insights to track […]

Epic Systems is a privately held healthcare software company that develops and offers a comprehensive suite of products designed to improve patient care and operational efficiency across various healthcare settings. Their software serves as a central nervous system for hospitals and health clinics, integrating nearly every aspect of patient care, from appointment scheduling and clinical […]

AppCatalyst is a healthcare mobile app development company that specializes in “Digital Front Door” solutions. Their primary goal is to empower consumers throughout critical moments in their healthcare journey. The company’s origins trace back to 2009, when they converted a highly-rated website symptom checker into a mobile application. This symptom checker, along with other content, […]

Syntra AI is a healthcare artificial intelligence company focused on streamlining and accelerating healthcare payments and administrative tasks. Their flagship product, Syntra Autonomous, automates pre-bill chart review, claim review, and submission. This system is designed to help medical practices identify missed revenue or compliance issues and improve billing accuracy and financial outcomes by applying AI-powered […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.